The Fate of Th17 Cells is Shaped by Epigenetic Modifications and Remodeled by the Tumor Microenvironment.

Fiche publication

Date publication

février 2020


International journal of molecular sciences


Membres identifiés du Cancéropôle Est :
Dr BINDA Delphine, Pr BORG Christophe, Pr GUITTAUT Michaël, Dr HERVOUET Eric, Dr PEIXOTO Paul, Dr LOYON Romain, Dr KROEMER Marie

Tous les auteurs :
Renaude E, Kroemer M, Loyon R, Binda D, Borg C, Guittaut M, Hervouet E, Peixoto P


Th17 cells represent a subset of CD4+ T cells characterized by the master transcription factor RORγt and the production of IL-17. Epigenetic modifications such as post-translational histone modifications and DNA methylation play a key role in Th17 cell differentiation and high plasticity. Th17 cells are highly recruited in many types of cancer and can be associated with good or bad prognosis. Here, we will review the remodeling of the epigenome induced by the tumor microenvironment, which may explain Th17 cell predominance. We will also discuss the promising treatment perspectives of molecules targeting epigenetic enzymes to remodel a Th17-enriched tumor microenvironment.

Mots clés

TIL, Th17 cells, epigenetic modifications, tumor microenvironment


Int J Mol Sci. 2020 Feb 29;21(5):